Work

Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma

Year: 2023

Type: article

Study design: Observational Study

Source: Journal of Gastroenterology

DOI: 10.1007/s00535-023-02011-9

Authors: Chenglin Xie, Xu Ye, Li Zeng, Xi Zeng, Deliang Cao

Institutions: Central South University, Hunan Cancer Hospital, Hunan Academy of Traditional Chinese Medicine, University of South China

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4385298797

FWCI: 3.346

Cites: 38

Cited by: 20

Related to: 10